Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03871556
Other study ID # STU002089391
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 20, 2019
Est. completion date October 2, 2022

Study information

Verified date September 2023
Source Northwestern University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to provide information about human subcutaneous fat thickness at different anatomic sites on the body by measuring these thicknesses with a diagnostic ultrasound and also by correlating patient perceptions of body image with measured fat distribution. Subjects currently living in the Chicago metropolitan area and meet inclusion/exclusion criteria will be considered for enrollment.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date October 2, 2022
Est. primary completion date October 2, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria: - Males or females 18-85 years old. - Subjects are in good health as judged by the investigator. - Subjects with Body Mass Index (BMI) between 18-29.99. - Subjects who are willing and have the ability to understand and provide informed consent for participation in the study and are able to communicate with the investigator Exclusion Criteria: - Evidence of another skin condition affecting the treatment area that would interfere with clinical assessments - Pregnant or breast feeding - Uncooperative patients or patients with neurological disorders who are incapable of following directions - Subjects who are unable to understand the protocol or give informed consent (including non-English speaking patients)

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
LOGIQ P6 Diagnostic Ultrasound
Ultrasound measurements of subcutaneous fat thickness

Locations

Country Name City State
United States Northwestern University Department of Dermatology Chicago Illinois

Sponsors (1)

Lead Sponsor Collaborator
Northwestern University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Difference in Thickness of Subcutaneous Fat at Different Anatomic Sites on the Body Will use diagnostic ultrasound to measure fat thickness through study completion, 1 day
Primary Gender Differences on Patient Perceptions of Body Image With Measured Fat Distribution Will use diagnostic ultrasound to measure fat thickness and a questionnaire to assess subject perceptions of their body using a 10-point Likert scale (1= very unsatisfied, 10= very satisfied) through study completion, 1 day
See also
  Status Clinical Trial Phase
Completed NCT04699669 - A Phase 1 Study to Evaluate the Safety and Tolerability of CBL-514 Injection on Convexity or Fullness of Abdominal Subcutaneous Fat in Healthy Volunteers Phase 1
Completed NCT02512822 - Usefulness of Non-invasive Radiofrequency Therapy for Facial Contouring N/A
Recruiting NCT06005441 - A Phase 2b Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat. Phase 2
Active, not recruiting NCT05736107 - A Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat Phase 2
Not yet recruiting NCT03160976 - Cryolipolysis on Localized Adiposity N/A
Completed NCT02098811 - Evaluation of the Safety and Precursors of Efficacy N/A
Active, not recruiting NCT04553627 - Feasibility of Producing the Appearance of a Gluteal Lift Post Cryolipolysis N/A
Completed NCT02539043 - Effects of Ultrasound Cavitation Focused on Located Adiposity N/A
Completed NCT01842802 - Clinical Investigation of Non Invasive Fat Reduction N/A
Completed NCT04698642 - A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of CBL-514 Injection for Reducing Convexity or Fullness of Abdominal Subcutaneous Fat Phase 2
Completed NCT02052622 - Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101 Phase 3
Completed NCT04897412 - A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Subcutaneous Fat (Stage 2) Phase 2
Completed NCT03682471 - Long-term 24-month Follow-up Study on Safety and Maintenance of Efficacy of ATX-101 (Sodium Deoxycholate Injection)
Completed NCT05234736 - A Study to Evaluate the Pharmacokinetic Profile of CBL-514 Injection in Healthy Volunteers Phase 2
Completed NCT04575467 - A Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Subcutaneous Fat (Stage 1) Phase 2